Free Trial
NYSE:LH

Labcorp (LH) Stock Price, News & Analysis

Labcorp logo
$258.60 +0.73 (+0.28%)
As of 11:22 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Labcorp Stock (NYSE:LH)

Key Stats

Today's Range
$256.64
$259.67
50-Day Range
$240.18
$264.18
52-Week Range
$198.96
$265.72
Volume
128,099 shs
Average Volume
639,698 shs
Market Capitalization
$21.64 billion
P/E Ratio
29.92
Dividend Yield
1.11%
Price Target
$276.08
Consensus Rating
Moderate Buy

Company Overview

Labcorp Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
89th Percentile Overall Score

LH MarketRank™: 

Labcorp scored higher than 89% of companies evaluated by MarketBeat, and ranked 111th out of 913 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Labcorp has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on 10 buy ratings, 2 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Labcorp has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Labcorp's stock forecast and price target.
  • Earnings Growth

    Earnings for Labcorp are expected to grow by 9.56% in the coming year, from $16.01 to $17.54 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Labcorp is 29.88, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.89.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Labcorp is 29.88, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.31.

  • Price to Earnings Growth Ratio

    Labcorp has a PEG Ratio of 1.66. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Labcorp has a P/B Ratio of 2.69. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Labcorp's valuation and earnings.
  • Percentage of Shares Shorted

    4.13% of the float of Labcorp has been sold short.
  • Short Interest Ratio / Days to Cover

    Labcorp has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Labcorp has recently increased by 10.61%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Labcorp pays a meaningful dividend of 1.10%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Labcorp does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Labcorp is 33.29%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Labcorp will have a dividend payout ratio of 16.42% next year. This indicates that Labcorp will be able to sustain or increase its dividend.

  • Read more about Labcorp's dividend.
  • Percentage of Shares Shorted

    4.13% of the float of Labcorp has been sold short.
  • Short Interest Ratio / Days to Cover

    Labcorp has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Labcorp has recently increased by 10.61%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Labcorp has a news sentiment score of 1.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 20 news articles for Labcorp this week, compared to 14 articles on an average week.
  • Search Interest

    3 people have searched for LH on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Labcorp to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Labcorp insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,928,714.00 in company stock.

  • Percentage Held by Insiders

    Only 0.84% of the stock of Labcorp is held by insiders.

  • Percentage Held by Institutions

    95.94% of the stock of Labcorp is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Labcorp's insider trading history.
Receive LH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Labcorp and its competitors with MarketBeat's FREE daily newsletter.

LH Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
Labcorp Hldgs Stock Guidance | NYSE:LH - Benzinga
See More Headlines

LH Stock Analysis - Frequently Asked Questions

Labcorp's stock was trading at $229.32 on January 1st, 2025. Since then, LH shares have increased by 12.7% and is now trading at $258.4950.

Labcorp Holdings Inc. (NYSE:LH) announced its earnings results on Tuesday, April, 29th. The medical research company reported $3.84 earnings per share for the quarter, beating the consensus estimate of $3.73 by $0.11. Labcorp's revenue was up 5.3% compared to the same quarter last year.
Read the conference call transcript
.

Labcorp subsidiaries include Clinical Outreach Laboratory Services, Personal Genome Diagnostics Inc., Toxikon Corporation, Myriad Autoimmune’s Vectra Testing Business, Ovia Health, Visiun, Envigo's nonclinical contract research services business, and others.

Top institutional shareholders of Labcorp include Delphi Management Inc. MA (0.01%), Parallel Advisors LLC, Ables Iannone Moore & Associates Inc. and Somerset Trust Co. Insiders that own company stock include Adam H Schechter, Glenn A Eisenberg, Brian J Caveney, Lance Berberian, Paul R Kirchgraber, Kerrii B Anderson, Dwight Gary Gilliland, Amy B Summy, Mark S Schroeder, Jonathan P Divincenzo, Der Vaart Sandra D Van and Peter J Wilkinson.
View institutional ownership trends
.

Shares of LH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Labcorp investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Last Earnings
4/29/2025
Record date for 6/11 Dividend
5/29/2025
Dividend Payable
6/11/2025
Today
7/08/2025
Next Earnings (Estimated)
7/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Health Care Services
Current Symbol
NYSE:LH
Previous Symbol
NYSE:LH?
Employees
70,000
Year Founded
1995

Price Target and Rating

Average Stock Price Target
$276.08
High Stock Price Target
$300.00
Low Stock Price Target
$230.00
Potential Upside/Downside
+7.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.79
Research Coverage
14 Analysts

Profitability

Trailing P/E Ratio
29.80
Forward P/E Ratio
16.10
P/E Growth
1.66
Net Income
$746 million
Pretax Margin
7.11%

Debt

Sales & Book Value

Annual Sales
$13.01 billion
Cash Flow
$22.05 per share
Price / Cash Flow
11.69
Book Value
$96.27 per share
Price / Book
2.68

Miscellaneous

Free Float
82,997,000
Market Cap
$21.58 billion
Optionable
Optionable
Beta
0.82

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:LH) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners